Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meetings, 34542-34543 [2014-14111]
Download as PDF
<![CDATA[
34542
Federal Register / Vol. 79, No. 116 / Tuesday, June 17, 2014 / Notices
investigate, examine, prosecute, sue
with respect to, defend against, correct,
remedy, or otherwise combat fraud,
waste or abuse in such programs.
8. To appropriate Federal agencies
and CMS contractors and consultants
that have a need to know the
information for the purpose of assisting
CMS’ efforts to respond to a suspected
or confirmed breach of the security or
confidentiality of information
maintained in this SOR, provided that
the information disclosed is relevant
and necessary for that assistance.
9. To the U.S. Department of
Homeland Security (DHS) cyber security
personnel, if captured in an intrusion
detection system used by HHS and DHS
pursuant to the Einstein 2 programs.
10. To disclose the personally
identifiable information of MA plan
enrollees to public health authorities,
and those entities acting under a
delegation of authority from a public
health authority, when requesting such
information to carry out statutorilyauthorized public health activities
pertaining to emergency preparedness
and response. Disclosures under this
routine use will be limited to ‘‘public
health authorities’’, ‘‘public health
activities’’, and ‘‘minimum necessary
data’’, as defined in the HIPAA Privacy
Rule (45 CFR 154.502, 164.512(b),
164.502(b) and 164.514(d)(3)(iii)(A)).
POLICIES AND PRACTICES FOR STORING,
RETRIEVING, ACCESSING, RETAINING, AND
DISPOSING OF RECORDS IN THE SYSTEM
All records are stored on magnetic
media.
RETRIEVABILITY:
All records are accessible by NPI/
NPPES or by beneficiary HICN. This
system supports both on-line and batch
access. The EDS system itself does not
provide reporting capabilities. All
reporting functionality can be found in
the IDR.
tkelley on DSK3SPTVN1PROD with NOTICES
SAFEGUARDS:
Personnel having access to the system
have been trained in the Privacy Act
and information security requirements.
Employees who maintain records in this
system are instructed not to release data
until the intended recipient agrees to
implement appropriate management,
operational, and technical safeguards
sufficient to protect the confidentiality,
integrity and availability of the
information and information systems,
and to prevent unauthorized access.
Access to records in the EDS will be
limited to CMS personnel and approved
contractors.
16:43 Jun 16, 2014
Jkt 232001
Records containing PII will be
maintained for a period of up to 10
years after entry in the database. Any
such records that are needed longer,
such as to resolve claims and audit
exceptions or to prosecute fraud, will be
retained until such matters are resolved.
Enrollee claims records are currently
subject to a document preservation
order and will be preserved indefinitely
pending further notice from the DOJ.
SYSTEM MANAGER AND ADDRESS:
Director, Division of Risk Adjustment
Payment and Policy, Medicare Plan
Payment Group, Center for Medicare,
Centers for Medicare & Medicaid
Services.
NOTIFICATION PROCEDURE:
Individuals wishing to know if this
system contains records about them
should write to the system managers
and include the pertinent personal
identifier used for retrieval of their
records (i.e., TIN, NPI or HICN).
RECORD ACCESS PROCEDURE:
Individuals seeking access to records
about them in this system should follow
the same instructions indicated under
‘‘Notification Procedure’’ and
reasonably specify the record contents
being sought. (These procedures are in
accordance with HHS Privacy Act
regulations at 45 CFR 5b.5 (a)(2)).
CONTESTING RECORD PROCEDURES:
STORAGE:
VerDate Mar<15>2010
RETENTION AND DISPOSAL:
Individuals seeking to contest the
content of information about them in
this system should follow the same
instructions indicated under
‘‘Notification Procedure.’’ The request
should reasonably identify the record
and specify the information being
contested; state the corrective actions
sought, and provide the reasons for the
correction, with supporting justification.
(These procedures are in accordance
with HHS Privacy Act regulations at 45
CFR 5b.7).
RECORD SOURCE CATEGORIES:
Sources of information contained in
this records system include data
collected from MA organizations and
encounter data obtained from the
provider, supplier, physician, or other
practitioner that furnished the item or
service.
SYSTEMS EXEMPTED FROM CERTAIN PROVISIONS
OF THE ACT:
None.
Celeste Dade-Vinson,
Health Insurance Specialist, Centers for
Medicare & Medicaid Services.
[FR Doc. 2014–14038 Filed 6–16–14; 8:45 am]
BILLING CODE 4120–03–P
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel, NEI Cornea and
Anterior Eye Grant Applications.
Date: July 21, 2014.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Anne E Schaffner, Ph.D.,
Chief, Scientific Review Branch Division of
Extramural Research, National Eye Institute,
5635 Fishers Lane, Suite 1300, MSC 9300,
Bethesda, MD 20892–9300, (301) 451–2020,
aes@nei.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS).
Dated: June 12, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–14109 Filed 6–16–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
E:\FR\FM\17JNN1.SGM
17JNN1
Federal Register / Vol. 79, No. 116 / Tuesday, June 17, 2014 / Notices
tkelley on DSK3SPTVN1PROD with NOTICES
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, Female
Contraceptive Development Program (U01).
Date: July 9, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Hotel at the Chevy
Chase Pavilion, 4300 Military Road
Northwest, Washington, DC 20015.
Contact Person: David Weinberg, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, NIH, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD 20892,
301–435–6973, David.Weinberg@nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, Prenatal Events—
Postnatal Consequences.
Date: July 10, 2014.
Time: 4:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852
(Telephone Conference).
Contact Person: Peter Zelazowski, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, NIH, 6100 Executive
Boulevard, Rm. 5B01, Bethesda, MD 20892–
7510, 301–435–6902,
peter.zelazowski@nih.gov.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review, Group Biobehavioral and Behavioral
Sciences Subcommittee Biobehavioral and
Behavioral Sciences.
Date: July 10–11, 2014.
Time: 8:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Mayflower Hotel, 1127
Connecticut Avenue NW., Washington, DC
20036.
Contact Person: Marita R. Hopmann, Ph.D.,
Scientific Review Administrator, Scientific
Review Branch, National Institute of Child
Health and Human Development, 6100
Building, Room 5B01, Bethesda, MD 20892,
(301) 435–6911, hopmannm@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, Population Centers
Infrastructure (P2C) Meeting.
Date: July 15, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Carla T. Walls, Ph.D.,
Scientific Review Administrator, Scientific
VerDate Mar<15>2010
16:43 Jun 16, 2014
Jkt 232001
Review Branch, National Institute of Child
Health and Human Development, NIH, 6100
Executive Blvd., Room 5B01, Bethesda, MD
20892, 301–435–6898, wallsc@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, Intellectual and
Developmental Disabilities Research Center
(IDDRC).
Date: July 21, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Mayflower Hotel, 1127
Connecticut Avenue NW., Washington, DC
20036.
Contact Person: MARITA R. HOPMANN,
Ph.D., Scientific Review Administrator,
Scientific Review Branch, National Institute
of Child Health and Human Development,
6100 Building, Room 5B01, Bethesda, MD
20892, (301) 435–6911,
hopmannm@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, CPCCRN Review.
Date: August 7–8, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Sherry L Dupere, Ph.D.,
Chief, Scientific Review Branch, Scientific
Review Branch, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD
20892–7510, 301–451–3415,
duperes@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, FMR1 CGG
Expansions: Prevalence, Transmission, and
Associated Phenotypes.
Date: August 7, 2014.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852.
Contact Person: David Weinberg, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, NIH, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD 20892,
301–435–6973, David.Weinberg@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS).
Dated: June 11, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–14111 Filed 6–16–14; 8:45 am]
PO 00000
Frm 00058
Fmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Inherited
Disease Research Access Committee.
Date: July 17, 2014.
Time: 11:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Camilla E. Day, Ph.D.,
Scientific Review Officer, CIDR, National
Human Genome Research Institute, National
Institutes of Health, 5635 Fishers Lane, Suite
4075, Bethesda, MD 20892, 301–402–8837,
camilla.day@nih.gov.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel, H3Africa ELSI.
Date: July 23, 2014.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, Suite 4076, 5635 Fishers Lane,
Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Rudy O. Pozzatti, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, 5635 Fishers Lane, Suite 4076, MSC
9306, Rockville, MD 20852, (301) 402–0838,
pozzattr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS).
Dated: June 12, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–14110 Filed 6–16–14; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
Sfmt 9990
34543
E:\FR\FM\17JNN1.SGM
17JNN1
]]>Agencies
[Federal Register Volume 79, Number 116 (Tuesday, June 17, 2014)]
[Notices]
[Pages 34542-34543]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-14111]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and
[[Page 34543]]
the discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel, Female Contraceptive Development
Program (U01).
Date: July 9, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites Hotel at the Chevy Chase Pavilion, 4300
Military Road Northwest, Washington, DC 20015.
Contact Person: David Weinberg, Ph.D., Scientific Review
Officer, Scientific Review Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human Development, NIH, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD 20892, 301-435-6973,
David.Weinberg@nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel, Prenatal Events--Postnatal
Consequences.
Date: July 10, 2014.
Time: 4:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference).
Contact Person: Peter Zelazowski, Ph.D., Scientific Review
Officer, Scientific Review Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human Development, NIH, 6100 Executive
Boulevard, Rm. 5B01, Bethesda, MD 20892-7510, 301-435-6902,
peter.zelazowski@nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Initial Review, Group Biobehavioral and Behavioral
Sciences Subcommittee Biobehavioral and Behavioral Sciences.
Date: July 10-11, 2014.
Time: 8:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Renaissance Mayflower Hotel, 1127 Connecticut Avenue NW.,
Washington, DC 20036.
Contact Person: Marita R. Hopmann, Ph.D., Scientific Review
Administrator, Scientific Review Branch, National Institute of Child
Health and Human Development, 6100 Building, Room 5B01, Bethesda, MD
20892, (301) 435-6911, hopmannm@mail.nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel, Population Centers
Infrastructure (P2C) Meeting.
Date: July 15, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Carla T. Walls, Ph.D., Scientific Review
Administrator, Scientific Review Branch, National Institute of Child
Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01,
Bethesda, MD 20892, 301-435-6898, wallsc@mail.nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel, Intellectual and Developmental
Disabilities Research Center (IDDRC).
Date: July 21, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Renaissance Mayflower Hotel, 1127 Connecticut Avenue NW.,
Washington, DC 20036.
Contact Person: MARITA R. HOPMANN, Ph.D., Scientific Review
Administrator, Scientific Review Branch, National Institute of Child
Health and Human Development, 6100 Building, Room 5B01, Bethesda, MD
20892, (301) 435-6911, hopmannm@mail.nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel, CPCCRN Review.
Date: August 7-8, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Sherry L Dupere, Ph.D., Chief, Scientific Review
Branch, Scientific Review Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human Development, NIH, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD 20892-7510, 301-451-3415,
duperes@mail.nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel, FMR1 CGG Expansions: Prevalence,
Transmission, and Associated Phenotypes.
Date: August 7, 2014.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Rockville, MD 20852.
Contact Person: David Weinberg, Ph.D., Scientific Review
Officer, Scientific Review Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human Development, NIH, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD 20892, 301-435-6973,
David.Weinberg@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS).
Dated: June 11, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-14111 Filed 6-16-14; 8:45 am]
BILLING CODE 4140-01-P
